Up to 50 cats are expected to participate in the trial, with their weight and health metrics monitored at three and six months.

Congress has the power to make obesity treatment and weight management accessible to the communities that need it.

BioAge Labs (NASDAQ: BIOA) is a small drugmaker whose shares have caught fire this year. The company has made clinical ...

Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, ...

Consuming too much soybean oil or omega-3 fatty acids may increase your risk for developing certain health issues, such as ...

The researchers found something surprising. People with both belly fat and low muscle mass had the highest risk of dying—83% ...

An anti-inflammatory diet supports metabolic and gut health, potentially lowering the risk of pancreatic cancer while ...

Retatrutide, Eli Lilly’s triple-hormone obesity drug, delivers up to 28.7% weight loss and major knee pain relief in ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...

But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to Mounjaro, Eli Lilly’s blockbuster that has become India’s top-selling drug ...

A single fast food meal significantly elevates triglycerides for up to six hours, impacting blood viscosity and arterial ...